EVALUATING THE QUALITY OF LIFE OF PATIENTS DIAGNOSED WITH HER2-POSITIVE BREAST CANCER IN VIETNAM BASED ON THE EORTC QLQ-C30 SCALE

Tô Huệ Nghi1, Trần Thị Yến Nhi1, Nguyễn Cao Đức Huy1, Nguyễn Thị Thu Thuỷ1,
1 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Background: Breast cancer has become a leading health concern worldwide, especially in women. Evaluating the health-related quality of life (HR-QoL) on patients helps clinicians to consider the optimum treatment, compare the current with the novel therapy. This study aimed to assess the HR-QoL of breast cancer patients by using a specialized questionnaire for cancer patients (EORTC QLQ-C30). Materials and methods: A cross-sectional descriptive study based on data collected from questionnaires and medical records of HER2-positive cancer patients treated at 6 hospitals including Bach Mai hospital, Cho Ray Hospital, Ho Chi Minh City Oncology Hospital, Da Nang Oncology Hospital, K Hospital, Ha Noi Oncology Hospital. Results: The survey sample included 338 patients with an average age of 53.87 ± 9.97 years old, most of which were in early stage (55.7%) and had not yet metastasized (76.6%). Based on the QLQ-C30 scale, the study recorded an overall QoL score of 60.11 ± 15.80. Among the functional scale, emotional, physical, and cognitive aspects had the highest score (77.79 ± 21.54, 75.35 ± 17.75 and 74.11 ± 22.92, respectively). In the symptom scale, insomnia and financial struggle were reported to be the most common and severe issues encountered during the treatment with the score of 55.82 ± 32.69 and 37.77 ± 30.11, respectively. Conclusion: HER2- positive breast cancer has moderate level of health-related quality of life.  Physical, emotional, and cognitive functions had relatively good scores, however cancer treatment caused financial difficulties for patients

Article Details

References

1. Lương Ngọc Khuê M. T. K. (2020), Hướng dẫn chẩn đoán và điều trị ung thư vú, 3128/QĐ-BYT, Bộ Y tế, Hà Nội.
2. Nguyễn Văn Cầu (2020), Nghiên cứu điều trị ung thư vú giai đoạn di căn bằng hóa trị phối hợp anthracycline và taxane, Sản phụ khoa, Đại học Y Dược Huế.
3. NNguyễn Thị Thu Thuỷ và cs. (2014), "Đánh giá gánh nặng kinh tế bệnh ung thư vú tại Việt Nam". 18, pp. 319-323.
4. Nguyễn Thu Hà và cs. (2017), "Chất lượng cuộc sống của người bệnh ung thư vú sử dụng thang đo QLQ-C30 và một số yếu tố liên quan tại một số bệnh viện Ung bướu tại Việt Nam", Tạp Chí Y học Dự Phòng. 27 (5).
5. Phạm Đình Hoàng và cs. (2019), "Đánh giá chất lượng cuộc sống của bệnh nhân nữ ung thư vú được điều trị tại Bệnh viện Quận Thủ Đức", Tạp chí Y học TP.HCM. 23 (5), pp. 141-147.
6. Do T. T. et al. (2020), "Contamination, suffering and womanhood: Lay explanations of breast cancer in Central Vietnam", Social Science & Medicine. 266, pp. 113360.
7. Ho P. J. et al. (2018), "Health-related quality of life in Asian patients with breast cancer: a systematic review", BMJ Open. 8 (4), pp. e020512.
8. Sung H. et al. (2021), "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries", CA Cancer J Clin. 71 (3), pp. 209-249.
9. Tsaras K. et al. (2018), "Assessment of Depression and Anxiety in Breast Cancer Patients: Prevalence and Associated Factors", Asian Pac J Cancer Prev. 19 (6), pp. 1661-1669.
10. Fayers P. M., N. Aaronson, and K. Bjordal, "The EORTC QLQ-C30 scoring manual (3rd Edition)", Journal of the National Cancer Institute 1993. 85, pp. 365-376.